SRF Webinar Series
83 - Oligos that target translation to restore SYNGAP1 levels
Bryan Dickinson, PhD
University of Chicago
82 - Behaviour, Cognition and Sensory Processing in People with SYNGAP1
Andrew Stanfield, MB, ChB, PhD
University of Edinburgh
81 - Illuminating the dynamic architecture and regulatory mechanisms of SynGAP
Eric S. Underbakke, PhD
Iowa State University
80 - Pérdida, duelo y resiliencia
José Antonio Solves Almela
79 - Quantifying perturbed SynGAP1 function caused by coding mutations
Michael Courtney, PhD
Turku Bioscience Centre, Finland
78 - Therapeutic Strategies for Autism: Targeting Three Levels of the Central Dogma of Molecular Biology - Presented to the SYNGAP1 Community
Prof. Lilia Iakoucheva, Ph.D. & Mr. Derek Hong, M.S.
UCSD School of Medicine
76 - Involvement of the brain endothelium in neurodevelopmental disorders like SYNGAP1
Baptiste Lacoste, PhD
The University of Ottawa
75 - Catatonia in Neurodevelopmental Conditions Like SYNGAP1
Joshua Ryan Smith, MD
Vanderbilt University Medical Center
74 - COMBINEDBrain Biobank & Our Partnership with SRF for SYNGAP1
Terry Jo Bichell, PhD, MPH
COMBINEDBrain
73 - Linking SYNGAP1 with Human-Specific Mechanisms of Neuronal Development
Pierre Vanderhaeghen, MD, PhD
VIB Center for Brain & Disease Research
71 - El Banco de cerebros y el Banco de Cerebros Hispanoamericano para Trastornos del Neurodesarrollo
Veronica Martinez-Cerdeno, PhD
UC Davis
70 - Brain Banking and the Hispano-American Brain Bank for Neurodevelopmental Disorders
Veronica Martinez-Cerdeno, PhD
UC Davis
69 - SYNGAP1 and Epilepsy Surgery: Is It Time To Consider A Different Toolbox?
Taylor Abel, MD & Monika Jones, JD
66 - Los registros de pacientes, clave para alcanzar un tratamiento
Dr. Carlos Caparros
Cámara Argentina de Organizaciones de Investigación Clínica
65 - Perros de Servicios para Syngap1
Cecilia Anastos
Meridus K9 & Equine, LLC
64 - SYNGAP Study - Seizure Tracker
Invitae/Ciitizen & Praxis
63 - Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides
Ben Prosser, PhD
University of Pennsylvania
59 - Finding more SYNGAP1 patients with Probably Genetic
Lukas Lange, CEO
Probably Genetic
58 - Expanding the ORCA Measure
Christy Zigler, PhD, MSED
Duke University
Monday, May 23, 2022
57 - Discussing SYNGAP1 Related Developmental Disorders
Holly Harris, MD
Baylor College of Medicine
55 - Evaluation of a Stem Cell Gene Therapy Approach for SYNGAP1
Joe Anderson, Ph.D., M.A.S.
University of California, Davis
April 28, 2022 @ 10am PT
54 - ABA Consult with Elemy Yeme
Elemy Yeme, MEd, BCBA
EY Behavioral Services
53 - Severe Behaviors and Advocacy
Jackie Kancir
Policy Committee | National Council on Severe Autism 21-22 Scholar | Partners in Policymaking™️
Wednesday, April 6, 2022 @ 9am PT/ 12pm ET
50 - The use of milk exosomes to increase the expression of SYNGAP1 in SYNGAP1 mice
Janos Zempleni, PhD
University of Nebraska
49 - Intro to RARE-X's SYNGAP1 Data Collection Program
Megan O'Boyle & Tom Hume
RARE-X
47 - An Introduction to Autism BrainNet
David Amaral, PhD, Scientific Director & Carolyn Komich Hare, MS, Clinical Director
Autism BrainNet
46 - La intención comunicativa en SYNGAP1
Marina Calleja Reina y Encarnación Postigo Pinazo
45.a - 3rd Annual Synapse Roundtable - Registry Updates on SYNGAP1 & STXBP1
Elli Brimble, MS, Research Director, Rare Disease
Ciitizen
45.b - 3rd Annual Synapse Roundtable Simons Searchlight Registry Insights
Wendy Chung, MD
Simons Searchlight
44 - Investigating the functional single cell biology of SYNGAP1 pathways
Michael Courtney, PhD
Turku Bioscience, Finland
Thurs., November 4th @ 10am PST/5pm GMT
43 - Manejo de expectativas al recibir un diagnóstico de Syngap1
Gaby Gerez, Psicóloga
el Sábado 16 de octubre @ 9am Columbia, 10am EST/Chile, 11am Argentina, 4pm Madrid
42 - ¿Que es Simons Searchlight?
Catherine Kentros, LGC, MMSc y Misia Kowanda, PhD y MSGC
Simons Searchlight
Sabado, Oct 2 @ 9 am EST, 10 am Chile, 3 pm Madrid, 8 am Colombia, 10 am Argentina
41 - efecto de las pantallas en el cerebro infantil
Sandra Catalina & Julio Cardona
Mesa Neuróloga pediatra; Neuropsicologo infantil
sábado 11 de septiembre a las 8 am Colombia, 9 am EST/Chile, 10am Argentina, 3pm Madrid
40 - Estrategias básicas para manejar los problemas de conducta y promover la comunicación
Carlos A. Zuluaga, M.S., BCBA
ABA Technologies, Inc. (USA)
5 de Septiembre @ 9am Columbia, 10am EST/Chile, 11am Argentina, 4pm Madrid
39 - Treatments in development for epilepsy syndromes: opportunities for Syngap1
Ana Mingorance, PhD
Dracaena Consulting
Thurs. Sept 2 - 10am PST/1pm EST
38 - Sistemas de comunicación alternativos aumentativos (SCAA). Caso de Charo con PECS y bimodal.
Ileana Glusko
Fonoaudiologa con especialización en terapia cognitiva conductual
08/28/2021
37 - Interpretation of SYNGAP1 Variants
Eduardo Pérez Palma, PhD
Centro de Genética y Genómica, Universidad del Desarrollo, Santiago (Chile)
Thurs., August 19 @ 10am PT - 1pm Chile
36 - Improving the assessment of SYNGAP1 by creating online measures for parents and patients
Dr. Thomas Frazier
John Carroll University
Saturday, July 17th, 2021 at 9 PST / Noon EST
35 - SynGAP modulates the body's biological clock: What Syngap1 mice can tell us about light & sleep
Sydney Aten, PhD
Ohio State University
Thursday, June 10 @ 10am Pacific
34 - Types of seizures and EEG patterns in SYNGAP1
Angel Aledo-Serrano, MD, PhD
Hospital Ruber Internacional (Madrid) & Clinica Corachan (Barcelona)
Thursday, May 27th @ 11 Eastern
33 - Functional assessment of missense variants of SYNGAP1
Kurt Haas, PhD
University of British Columbia
Thursday, May 13 at 10 Pacific
32 - Let Me Hear YOUR Voice: Effecting Change through Effective Advocacy
Lorri Unumb Esq.
The Council of Autism Service Providers
May 6th, 2021
31 - An integrated approach to investigating GI & neurological comorbidities caused by SYNGAP1
Drs Dallman, Jimenez & Moshiree
University of Miami
April 22nd, 2021
30 - Sindrome del Cuidador Agotado
Dra. Piedad Jaramillo Arias
Universidad de Caldas
Sabado Abril 17, 2021
29 - SSB30 Study: Seizures, Sleep & Behavior Study - 30 consecutive days of data - Ciitizen / SYNGAP1
Virginie McNamar
Ciitizen
Thursday April 15th, 2021
28 - Modulating gene regulation to treat gene dosage-associated diseases
Prof. Nadav Ahituv, PhD
UCSF
April 1st, 2021 @ 10 AM Pacific
27 - Cultivando Esperanza con ABA: Estrategias de Comportamiento para Pacientes con Syngap1
Elemy Yeme, MEd, BCBA
ElevABA, LLC
Marzo 27 @ 11 AM EST/Colombia y 5 pm Madrid
26 - Your teenager was just diagnosed with SYNGAP1, processing through a new lens
Jo Ashline
Syngap mom
March 25th, 2021 at 9 am Pacific
25 - Cultivating hope with ABA: Behavior managment strategies for SYNGAP1 patients
Elemy Yeme, MEd, BCBA
ElevABA
March 6th @ 9AM PST
24 - Behavioural and cellular pathophysiology in a rat model of SYNGAP1 haploinsufficiency
Prof. Peter Kind, PhD
University of Edinburgh
Feb 11th, 2021 @ 9 PST, 5 GMT.
23 - Cognition, behavior & clinical trials in SYNGAP1
Andrew Stanfield, PhD
Univ. of Edinburgh
22 - SRF in 2021
Dr. Hans Schlecht
Syngap Research Fund
20 - SYNGAP1 from the Clinics
Dr. Connie Smith-Hicks
Johns Hopkins
19 - Correcting Premature Stop Codon Mutations using Anticodon Edited Transfer RNA
Dr. Alfred L. George, Jr. & Dr. Christopher Ahern
Northwestern & University of Iowa
16 - Understanding SynGAP1
Dr. Elizabeth Heller
UPenn
15 - Three Functions of SynGAP
Dr. Mary Kennedy PhD
Caltech
14 - SYNGAP1 in Translation: From Deep Phenotyping to Human Neurons
Dr. Jimmy Holder
Baylor
December, 2020
12 - Keto, MAD & SynGAP Parents Experience
Syngap1 Parents
10/15/2019 1:00 PM PT
4 - Epigenetics research will benefit the SynGAP community
Dr. Elizabeth Heller
UPenn Epigenetics
1 - SYNGAP1 Research Roadmap - June 18, 2020
Dr. Rumbaugh
Scripps
June 18, 2020
.jpeg)
.svg)